Overview

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of this clinical trial is to compare the efficacy and safety of ritonavir (RTV)-boosted atazanavir with nevirapine, each on a background of emtricitabine and tenofovir disoproxil fumarate (DF).

Phase:

Phase 4

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Atazanavir Sulfate
Emtricitabine
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Nevirapine
Ritonavir
Tenofovir